Aura Research And Remedies Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.45 Cr
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 61.23%
- Ebitda 61.23%
- Net Worth 4137.02%
- Total Assets 4119.33%
About Aura Research And Remedies
Aura Research And Remedies Private Limited (ARARPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 March 2021 (Three years and ten months 29 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Akkisani and Prathima Arveti serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100TG2021PTC149695
-
Company No.
149695
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Mar 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Aura Research And Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akkisani
|
Managing Director | 16-Mar-2021 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Prathima Arveti
|
Director | 17-Aug-2023 | Current |
Financial Performance of Aura Research And Remedies.
Aura Research And Remedies Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 61.23% increase in profit. The company's net worth Soared by an impressive increase of 4137.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aura Research And Remedies?
In 2023, Aura Research And Remedies had a promoter holding of 49.65% and a public holding of 50.35%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Stereo Drugs Private LimitedAkkisani and Prathima Arveti are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aura Research And Remedies?
Aura Research And Remedies has a workforce of 0 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aura Research And Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aura Research And Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
